Eviva Partners, a New Nonprofit Promoting Better Understanding of Medical Evidence, Exposes Role of Andrew Wakefield in the “Manufacture of Evidence” Leading Up to Robert F. Kennedy Jr’s Confirmation Hearings

Introduces the concept of "Evidence Fluency" as a solution to the current crisis and a path towards improving healthcare overall

NEW YORK CITY, NEW YORK / ACCESS Newswire / February 10, 2025 / Eviva Partners, a pioneering healthcare initiative founded by physician-scientist Alex Morozov, announced its launch today with an innovative mission to address critical gaps in healthcare delivery through "evidence fluency" - a new framework for understanding and communicating medical evidence.

"The new US Administration is poised to have a dramatic impact on the integrity of scientific publications and medical evidence," said Alex Morozov, CEO and Founder. "An investigation over the past several days reveals a role of Andrew Wakefield in the "Manufacture of Evidence" leading up to Robert F. Kennedy Jr's Confirmation hearings. Wakefield 30 years ago was paid by another anti-vaccine lawyer, Richard Barr, to manufacture a study through research fraud showing a link between vaccines and autism. History now repeats itself, except now the anti-vaccine lawyer, Kennedy, could become in charge of US science and medicine as a whole."

Eviva Partners's solution to this crisis is simple: "Evidence Fluency." The premise is that one key, previously overlooked factor underlies the current challenges of poor and unequal outcomes and rising costs in the U.S. healthcare system: insufficient "evidence fluency" among patients, providers, and other healthcare stakeholders.

"We are a nonpartisan organization committed to helping improve health outcomes for all" said Morozov.

Eviva Partners introduces the concept of "evidence fluency" as a solution to the current crisis and a path towards improving healthcare overall, defined as having four components:

• Understanding the concept of evidence as distinct from "proof;"

• Ability to assess the strength of evidence;

• Ability to detect manipulation;

• Ability to discuss evidence with others.

Eviva Partners will focus on three areas:

1. Pioneering deep characterization of care gaps (both underuse and overuse), starting in hematology-oncology care, at the state level;

2. Developing a multi-pronged approach to increase evidence fluency through:

   • "Two-Eyed Seeing" methodology for bridging worldviews

   • K-12 evidence curriculum

   • A tool kit for patients and providers

3. Creating state and federal policy proposals to improve healthcare transparency and quality, starting with protecting the integrity of scientific literature.

The organization has assembled a distinguished advisory council including Elder Albert Marshall of the Mi'kmaw Nation, creator of the "Two-Eyed Seeing" methodology; Stephan Lewandowsky, a leading cognitive scientist at the University of Bristol, and others.

"Our preliminary surveys show that only 16% of U.S. adults correctly understand the difference between evidence and proof, while 36% have never heard the word 'evidence' used in a medical context," said Morozov. "By improving evidence fluency across the healthcare ecosystem, we can help close care gaps and ultimately improve health outcomes for all."

Initial pilot studies will focus on sickle cell disease and cancer, where care gaps are high. In addition, K-12 evidence curriculum will be piloted. Once those are completed, the organization plans to launch a nationwide public awareness campaign to promote evidence fluency.

For more information about Eviva Partners, and to read Alex Morozov's expose, "Robert F. Kennedy Jr, Andrew Wakefield and The Manufacture of Evidence," visit www.evivapartners.org, or follow Eviva Partners on Twitter, BlueSky, LinkedIn, Facebook and Instagram.

SOURCE: Eviva Partners